This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 1989 Apr 1;63(12):867-9.

doi: 10.1016/0002-9149(89)90059-3.

When is QT prolongation antiarrhythmic and when is it proarrhythmic?

PMID: 2929445
DOI: 10.1016/0002-9149(89)90059-3

Editorial

When is QT prolongation antiarrhythmic and when is it proarrhythmic?

B N Singh. Am J Cardiol. 1989.

. 1989 Apr 1;63(12):867-9.

doi: 10.1016/0002-9149(89)90059-3.

Author

PMID: 2929445
DOI: 10.1016/0002-9149(89)90059-3

No abstract available

PubMed Disclaimer

Similar articles

Proarrhythmic and Torsadogenic Effects of Potassium Channel Blockers in Patients.
McCauley M, Vallabhajosyula S, Darbar D. McCauley M, et al. Card Electrophysiol Clin. 2016 Jun;8(2):481-93. doi: 10.1016/j.ccep.2016.02.009. Epub 2016 Mar 22. Card Electrophysiol Clin. 2016. PMID: 27261836 Free PMC article. Review.
[Cardiac side effects of anti-arrhythmia agents].
Seipel L. Seipel L. Z Kardiol. 1988 Feb;77(2):77-88. Z Kardiol. 1988. PMID: 3284219 Review. German.
[Anti-arrhythmia drugs in geriatric patients].
Hohnloser SH, Zabel M. Hohnloser SH, et al. Fortschr Med. 1991 Aug 30;109(25):492-5. Fortschr Med. 1991. PMID: 1937335 Review. German.
Antiarrhythmic agents and the danger of proarrhythmic events.
Josephson ME. Josephson ME. Ann Intern Med. 1989 Jul 15;111(2):101-3. doi: 10.7326/0003-4819-111-2-101. Ann Intern Med. 1989. PMID: 2662846 Review. No abstract available.
[Ventricular arrhythmias: diagnosis and drug therapy].
Schüpfer C, Gertsch M. Schüpfer C, et al. Praxis (Bern 1994). 1996 May 14;85(20):647-54. Praxis (Bern 1994). 1996. PMID: 8685556 Review. German.

See all similar articles

Cited by

The effects of L-thyroxine treatment on QT dispersion in primary hypothyroidism.
Kweon KH, Park BH, Cho CG. Kweon KH, et al. J Korean Med Sci. 2007 Feb;22(1):114-6. doi: 10.3346/jkms.2007.22.1.114. J Korean Med Sci. 2007. PMID: 17297262 Free PMC article.
Controlling cardiac arrhythmias: to delay conduction or to prolong refractoriness.
Singh BN. Singh BN. Cardiovasc Drugs Ther. 1989 Oct;3(5):671-4. doi: 10.1007/BF01857618. Cardiovasc Drugs Ther. 1989. PMID: 2488106 Review.
Evaluation of Ondansetron-induced QT interval prolongation in the prophylaxis of postoperative emesis.
Gupta SD, Pal R, Sarkar A, Mukherjee S, Mitra K, Roy S, Sarbapalli D, Kundu KK, Zaman FA, Kar S. Gupta SD, et al. J Nat Sci Biol Med. 2011 Jan;2(1):119-24. doi: 10.4103/0976-9668.82306. J Nat Sci Biol Med. 2011. PMID: 22470245 Free PMC article.
QT-interval prolonging drugs: mechanisms and clinical relevance of their arrhythmogenic hazards.
Zehender M, Hohnloser S, Just H. Zehender M, et al. Cardiovasc Drugs Ther. 1991 Apr;5(2):515-30. doi: 10.1007/BF03029779. Cardiovasc Drugs Ther. 1991. PMID: 1854661 Review.
The role of pharmacologic treatment to prevent sudden death in the implantable cardioverter defibrillator era.
Elliott PM. Elliott PM. Curr Cardiol Rep. 2001 Mar;3(2):167-72. doi: 10.1007/s11886-001-0045-6. Curr Cardiol Rep. 2001. PMID: 11177676 Review.

See all "Cited by" articles

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information